Molecular-field-based three-dimensional similarity studies on quinoline-based CNS active agents

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Neuroscience

Background:

• Central nervous system (CNS) agents are crucial for treating neurological and psychiatric disorders.
• Understanding the three-dimensional (3D) structural properties of CNS-active compounds is vital for drug design.
• Quinoline derivatives represent a promising scaffold for developing novel CNS therapeutics.

Purpose of the Study:

• To evaluate the 3D structural similarity of novel quinoline-based agents to established atypical antipsychotics.
• To identify potential structural relationships between quinoline derivatives and known antipsychotic drug classes.
• To guide the development of new CNS agents with improved efficacy and specificity.

Main Methods:

• Utilized molecular field analysis to represent molecules based on electrostatic, van der Waals, and hydrophobic potentials.
• Aligned molecules using identified "field points" to quantify 3D similarity.
• Compared a series of quinoline-based agents against a panel of standard atypical antipsychotics, including clozapine, ketanserin, ziprasidone, and risperidone.

Main Results:

• Quinoline-based agents exhibited lower 3D similarity to clozapine, a dibenzodiazepine derivative.
• Higher 3D similarity values were observed between the quinoline series and extended chain compounds such as ketanserin, ziprasidone, and risperidone.
• The obtained similarity data correlated well with previously reported physicochemical similarity assessments.

Conclusions:

• The 3D structural analysis provides insights into the potential mechanism of action and receptor interactions of quinoline-based CNS agents.
• Findings suggest that quinoline derivatives may share structural features with certain atypical antipsychotics, potentially targeting similar pathways.
• This study aids in the rational design of quinoline-based compounds as potential antipsychotic drug candidates.